Brandinium

Trademark search for:

ZAPIRAM

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2000-07-14 — Application filed
  • 2000-11-03 — Assigned to examiner
  • 2000-11-06 — Final disposition recorded
  • 2001-08-13 — Application abandoned
  • 2001-10-17 — Reinstated
  • 2001-10-19 — Letter of suspension mailed
  • 2001-11-09 — Examiners amendment mailed
  • 2001-11-09 — Sec. 44(d) claim deleted
  • 2001-11-09 — Correspondence received in law office
  • 2001-11-30 — Approved for pub - principal register
  • 2002-02-20 — Notice of publication
  • 2002-03-12 — Published for opposition
  • 2002-06-04 — Noa mailed - sou required from applicant
  • 2002-11-08 — Sou extension 1 filed
  • 2002-11-18 — Paper received
  • 2003-03-31 — Sou extension 1 granted
  • 2003-06-04 — Paper received
  • 2003-06-04 — Sou extension 2 filed
  • 2003-06-04 — Sou extension 2 granted
  • 2003-12-04 — Sou teas extension received
  • 2003-12-04 — Sou extension 3 filed
  • 2003-12-17 — Sou extension 3 granted
  • 2004-06-04 — Sou teas extension received
  • 2004-06-04 — Sou extension 4 filed
  • 2004-06-04 — Sou extension 4 granted
  • 2004-06-14 — Case file in ticrs
  • 2004-12-04 — Sou teas extension received
  • 2004-12-04 — Sou extension 5 filed
  • 2004-12-09 — Sou extension 5 granted
  • 2005-04-21 — Paper received
  • 2005-04-24 — Petition to director received
  • 2005-06-04 — Notice of allowance cancelled
  • 2005-06-16 — Petition to director granted
  • 2005-10-25 — Application abandoned
  • 2005-10-25 — Application abandoned
  • 2006-01-03 — Reinstated
  • 2006-01-06 — 1(b) basis deleted; new basis approved
  • 2006-01-13 — Assigned to lie
  • 2006-03-17 — Post publication amendment - entered
  • 2006-03-17 — Law office publication review completed
  • 2006-04-19 — Notice of publication
  • 2006-05-09 — Published for opposition
  • 2006-08-01 — Registered-principal register
  • 2007-07-24 — Teas revoke/app/change addr of atty/dom rep received
  • 2007-07-24 — Attorney/dom.rep.revoked and/or appointed
  • 2013-03-08 — Cancelled sec. 8 (6-yr)
  • 2013-03-08 — Final status recorded

Owner Information

AstraZeneca AB
SE
AstraZeneca AB
SE
AstraZeneca AB
SE

Correspondent

Wm. Charles Saunders AstraZeneca Pharmaceuticals LP
1800 Concord Pike
OW2
Wilmington, DE 19850

Filing Details

Filing Date:
2000-07-14
Status Date:
2013-03-08
Category:
Pharmaceuticals
Filing Year:
2000

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.